![Gregory Demopulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Demopulos
Chief Executive Officer at
OMEROS CORPORATION
Net worth: 16 M $ as of 2026-05-30
Profile
Gregory A. Demopulos is the founder of Omeros Corp., founded in 1994, holding the titles of Chairman, President & Chief Executive Officer since 2013.
Current jobs include Director at Onconome, Inc., Director at Tessera, Inc., Director at Northwest NeuroNeighborhood, and Trustee at Smead Funds Trust.
Education history includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OMEROS CORPORATION 2.03% | 2026-04-16 | 1,469,308 ( 2.03% ) | 16 M $ | 2026-05-30 |
Gregory Demopulos active positions
| Companies | Position | Start |
|---|---|---|
| OMEROS CORPORATION | Chief Executive Officer | 1994-06-15 |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Director/Board Member | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Director/Board Member | - |
Smead Funds Trust
 Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Director/Board Member | - |
Northwest NeuroNeighborhood | Director/Board Member | - |
Training of Gregory Demopulos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Health Technology |
Smead Funds Trust
Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Electronic Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwest NeuroNeighborhood |
- Stock Market
- Insiders
- Gregory Demopulos
